NCT07322094
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07322094
Title CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ovarian Cancer
Acronym CATALINA-4
Recruitment Recruiting
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors TORL Biotherapeutics, LLC
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
UCLA RECRUITING Los Angeles California 90095 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field